Navigation Links
China BCT Reports First Quarter 2010 Results
Date:5/21/2010

(44,919) -- Loss on disposal of property, plant and equipment -- 306 Amortization of intangible assets 34,514 29,024 Amortization of land use rights 108,355 83,873 Change in fair value of warrant liabilities 288,783 -- Changes in operating assets and liabilities:- Trade receivables 299,603 (7,574,526) Bills receivable (129,956) -- Other receivables, prepayments and deposits (1,528,878) (1,477,625) Inventories (2,015,522) (440,823) Trade payables 1,584,966 (1,397,972) Amounts due from (to) related companies 388,390 (277,722) Other payables and accrued expenses 591,850 1,463,456 Bills payable (496,176) 2,223,521 Restricted cash 284,065 (2,201,559) Income tax payable 119,648 344,597 Net cash flows provided by (used in) operating activities $3,909,151 $(4,059,740) China BCT Pharmacy Group, Inc. (Formerly named China Baicaotang Medicine Limited) Condensed Consolidated Statements of Cash Flows (Cont'd) For the three months ended March 31, 2010 and 2009 (Unaudited) (Stated in US Dollars)
'/>"/>
SOURCE China BCT Pharmacy Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
2. OriGene Technologies, Inc. to Build the Worlds Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China
3. China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results
4. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 63rd PHARMACHINA Fair
5. China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit
6. China Sky One Medical Provides Sales Forecast for 13 New Products
7. China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
8. Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
9. China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results
10. China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call
11. China Medicine Announces Conference Call to Discuss First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... +14% CER / 20% of sales) led the regional performance in the second ... well as solid contributions from Korea, India and ... East / Africa (Q2 2015: +3% CER ... Turkey and the United Kingdom . The ... HPV sales, on demand across all customer classes. The top seven emerging markets ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... , July 29, 2015  Indivior PLC (LON: INDV) ... naloxone nasal spray was accepted and received Priority Review ... the treatment of opioid overdose. This naloxone nasal spray ... formulated for optimal absorption into the nasal mucosa. 1 ... training so individuals may be better equipped to help ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi LifeSciences™ formalized ... specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and ... PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical ...
Breaking Biology Technology:QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3
... developed a new type of probe that allows them ... cells more easily than existing methods. The tool will ... living cells. , Techniques scientists currently use to image ... drawbacks, including the need for synthetic RNA or a ...
... HOPKINTON, Mass., April 6 Caliper Life Sciences, Inc. (Nasdaq: ... Meeting of Stockholders will be held on June 2, 2009, ... 68 Elm Street, Hopkinton, Massachusetts. The record date for ... 16, 2009. About Caliper Life Sciences ...
... April 6 /PRNewswire/ - Orcrist Bio Inc. (ORC) ... today the approval of its Phase I, open-label, ... volunteers, by the European Competent Authority in Seville, ... assess the safety, tolerability, pharmacokinetics and pharmacodynamics (induction ...
Cached Biology Technology:Researchers develop new way to see single RNA molecules inside living cells 2Researchers develop new way to see single RNA molecules inside living cells 3Orcrist Bio Inc. Receives Approval from European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2
(Date:7/20/2015)... July 20, 2015  Acuity Market Intelligence,s latest ... Convergence of Commerce and Privacy" forecasts that between ... apps will be downloaded to smart mobile devices ... biometrics market is projected to generate more than ... the seven-year forecast period.    "Biometrics ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... -- April 12, 2010 For millions of Americans with ... typically in adulthood) the associated risk of cancer is of ... insulin whether naturally produced by the body or injected ... of some common cancers. With the release ...
... world,s largest antimony mine has become the world,s largest ... -- an element whose environmental and biological properties are ... contaminant," said IU Bloomington Ph.D. student Faye Liu, the ... to it." Used in small quantities, antimony has ...
... international research team co-led by the Ontario Cancer Institute ... cells a discovery that will accelerate developing targeted ... lymphoma. The research findings, published online today ... the scientists used a chemical compound to block protein ...
Cached Biology News:Case Western Reserve team discovers 'smart' insulin molecule 2A different kind of mine disaster 2A different kind of mine disaster 3
Mycoplasma tested...
RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays) Class: Antibody Array Products Product Group: Antibody Array...
...
Request Info...
Biology Products: